<p>LaSalle St. Investment Advisors LLC 在第一季度将其在强生（NYSE:JNJ - 免费报告）的股份增加了 16.8%，根据该公司最近向证券交易委员会提交的 13F 表格。该基金在此期间额外购买了 1,776 股后，持有该公司 12,356 股股票。截至其最近向证券交易委员会提交的文件，LaSalle St. Investment Advisors LLC 在强生的持股价值为 2,049,000 美元。</p>
<p>获取 <strong>强生</strong> 的提醒：</p>
<ul>
<li>担心反弹消退？考虑这三只分红股票</li>
</ul>
<p>其他大型投资者最近也调整了对该公司的持股。Elios Financial Group Inc. 在第一季度将其在强生的股份增加了 1.5%。Elios Financial Group Inc. 目前持有 4,496 股该公司股票，价值 746,000 美元，此前在此期间额外购买了 66 股。Atlantic Family Wealth LLC 在第一季度将其在强生的股份增加了 4.4%。Atlantic Family Wealth LLC 目前持有 1,603 股该公司股票，价值 266,000 美元，此前在上个季度额外购买了 67 股。MBA Advisors LLC 在第一季度将其在强生的股份增加了 1.2%。MBA Advisors LLC 目前持有 5,553 股该公司股票，价值 921,000 美元，此前在上个季度额外购买了 68 股。Sovereign Financial Group Inc. 在第一季度将其在强生的股份增加了 1.8%。Sovereign Financial Group Inc. 目前持有 3,928 股该公司股票，价值 651,000 美元，此前在上个季度额外购买了 69 股。最后，Nabity Jensen Investment Management Inc 在第一季度将其在强生的股份增加了 1.5%。Nabity Jensen Investment Management Inc 目前持有 4,624 股该公司股票，价值 767,000 美元，此前在上个季度额外购买了 69 股。目前 69.55% 的股票由机构投资者和对冲基金持有。</p>
<h2>华尔街分析师观点</h2>
<p>几家券商最近对 JNJ 进行了评论。Wall Street Zen 在 7 月 18 日的研究报告中将强生的评级从 “强力买入” 下调至 “买入”。瑞银集团在 7 月 17 日的研究报告中将强生的目标价从 180.00 美元上调至 190.00 美元，并给予该公司 “买入” 评级。Piper Sandler 在 7 月 17 日的研究报告中重申了对强生股票的 “增持” 评级。美国银行在 7 月 17 日的研究报告中将强生的目标价从 161.00 美元上调至 175.00 美元，并给予该股票 “中性” 评级。最后，Benchmark 在 4 月 24 日的报告中将强生升级为 “强力买入” 评级。九位股票研究分析师对该股票给予了持有评级，十位给予了买入评级，两位给予了强力买入评级。根据 MarketBeat 的数据，该公司目前的共识评级为 “适度买入”，平均目标价为 174.50 美元。</p>
<ul>
<li>三只强劲盈利的高分红股票</li>
</ul>
<p><strong>获取我们关于强生的最新股票报告</strong></p>
<h2>强生股票表现</h2>
<p>强生的股票在周五开盘价为 171.41 美元。该公司的债务与股本比率为 0.50，流动比率为 1.01，速动比率为 0.76。强生的年内最低价为 140.68 美元，年内最高价为 172.18 美元。该公司的 50 日移动平均价格为 158.89 美元，200 日移动平均价格为 157.27 美元。该公司的市值为 4,128.1 亿美元，市盈率为 18.33，市盈增长比率为 2.17，贝塔值为 0.41。</p>
<ul>
<li>四只主要股票上调 2025 年指引，分析师目标上升</li>
</ul>
<p>强生（NYSE:JNJ - 获取免费报告）最近于 7 月 16 日发布了季度财报。该公司报告季度每股收益为 2.77 美元，超出分析师一致预期的 2.68 美元，超出 0.09 美元。该公司季度收入为 237.4 亿美元，而分析师预期为 228.5 亿美元。强生的股本回报率为 32.49%，净利润率为 25.00%。强生的收入较去年同期增长了 5.8%。去年同期，该公司每股收益为 2.82 美元。整体而言，分析师预计强生在当前年度的每股收益将达到 10.58 美元。</p>
<h2>强生分红公告</h2>
<p>该公司最近还宣布了一项季度分红，将于 9 月 9 日（星期二）支付。8 月 26 日（星期二）的股东将获得 1.30 美元的分红。这相当于每年 5.20 美元的分红，收益率为 3.0%。该分红的除息日为 8 月 26 日（星期二）。强生的分红支付比率（DPR）目前为 55.61%。</p>
<h2>强生简介</h2>
<p>（免费报告）</p>
<p>强生是一家控股公司，专注于医疗保健领域的产品研究、开发、制造和销售。它通过创新药物和医疗技术两个部门运营。创新药物部门专注于免疫学、传染病、神经科学、肿瘤学、心血管和代谢以及肺动脉高压。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们更看好的股票超过强生</li>
<li>如何计算股票利润</li>
<li>三只推动下一次科技革命的人工智能基础设施股票</li>
<li>如何使用 MarketBeat 股票筛选器</li>
<li>为什么单片电源的收益和指引引发了反弹</li>
<li>什么是道琼斯狗策略？概述和示例</li>
<li>AppLovin 的第二季度业绩不佳让市场感到恐慌，但华尔街却加倍下注</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUpOSg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUpOSg"/></p>
<p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，旨在为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元在强生吗？</h2>
<p>在考虑强生之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而强生并不在名单上。</p>
<p>虽然强生目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

强生

<p>LaSalle St. Investment Advisors LLC 在第一季度将其在强生（NYSE: JNJ）的持股增加了 16.8%，额外购买了 1,776 股，总持股达到 12,356 股，价值为 2,049,000 美元。其他投资者也调整了他们的持股。分析师对 JNJ 的评级意见不一，普遍评级为 “适度买入”，平均目标价为 174.50 美元。JNJ 的股票开盘价为 171.41 美元，市值为 4,128.1 亿美元，市盈率为 18.33。该公司报告上个季度每股收益为 2.77 美元，超出预期</p>

<p>LaSalle St. Investment Advisors LLC grew its stake in Johnson &amp; Johnson (NYSE:JNJ - Free Report) by 16.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,356 shares of the company's stock after acquiring an additional 1,776 shares during the period. LaSalle St. Investment Advisors LLC's holdings in Johnson &amp; Johnson were worth $2,049,000 as of its most recent filing with the Securities and Exchange Commission.</p>
<div class="lb-trans"><p>LaSalle St. Investment Advisors LLC 在第一季度将其在强生（NYSE:JNJ - 免费报告）的股份增加了 16.8%，根据该公司最近向证券交易委员会提交的 13F 表格。该基金在此期间额外购买了 1,776 股后，持有该公司 12,356 股股票。截至其最近向证券交易委员会提交的文件，LaSalle St. Investment Advisors LLC 在强生的持股价值为 2,049,000 美元。</p>
</div><p>Get <strong>Johnson &amp; Johnson</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>强生</strong> 的提醒：</p>
</div><ul>
<li>Worried About a Fading Rally? Consider These 3 Dividend Stocks</li>
</ul>
<div class="lb-trans"><ul>
<li>担心反弹消退？考虑这三只分红股票</li>
</ul>
</div><p>Other large investors also recently modified their holdings of the company. Elios Financial Group Inc. boosted its stake in Johnson &amp; Johnson by 1.5% in the 1st quarter. Elios Financial Group Inc. now owns 4,496 shares of the company's stock valued at $746,000 after purchasing an additional 66 shares during the period. Atlantic Family Wealth LLC boosted its position in shares of Johnson &amp; Johnson by 4.4% during the 1st quarter. Atlantic Family Wealth LLC now owns 1,603 shares of the company's stock worth $266,000 after acquiring an additional 67 shares in the last quarter. MBA Advisors LLC increased its stake in Johnson &amp; Johnson by 1.2% in the first quarter. MBA Advisors LLC now owns 5,553 shares of the company's stock valued at $921,000 after acquiring an additional 68 shares during the last quarter. Sovereign Financial Group Inc. lifted its stake in Johnson &amp; Johnson by 1.8% during the first quarter. Sovereign Financial Group Inc. now owns 3,928 shares of the company's stock worth $651,000 after purchasing an additional 69 shares during the last quarter. Finally, Nabity Jensen Investment Management Inc increased its stake in shares of Johnson &amp; Johnson by 1.5% in the 1st quarter. Nabity Jensen Investment Management Inc now owns 4,624 shares of the company's stock valued at $767,000 after purchasing an additional 69 shares during the last quarter. 69.55% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他大型投资者最近也调整了对该公司的持股。Elios Financial Group Inc. 在第一季度将其在强生的股份增加了 1.5%。Elios Financial Group Inc. 目前持有 4,496 股该公司股票，价值 746,000 美元，此前在此期间额外购买了 66 股。Atlantic Family Wealth LLC 在第一季度将其在强生的股份增加了 4.4%。Atlantic Family Wealth LLC 目前持有 1,603 股该公司股票，价值 266,000 美元，此前在上个季度额外购买了 67 股。MBA Advisors LLC 在第一季度将其在强生的股份增加了 1.2%。MBA Advisors LLC 目前持有 5,553 股该公司股票，价值 921,000 美元，此前在上个季度额外购买了 68 股。Sovereign Financial Group Inc. 在第一季度将其在强生的股份增加了 1.8%。Sovereign Financial Group Inc. 目前持有 3,928 股该公司股票，价值 651,000 美元，此前在上个季度额外购买了 69 股。最后，Nabity Jensen Investment Management Inc 在第一季度将其在强生的股份增加了 1.5%。Nabity Jensen Investment Management Inc 目前持有 4,624 股该公司股票，价值 767,000 美元，此前在上个季度额外购买了 69 股。目前 69.55% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>Several brokerages recently commented on JNJ. Wall Street Zen lowered Johnson &amp; Johnson from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a research report on Friday, July 18th. UBS Group lifted their price objective on Johnson &amp; Johnson from $180.00 to $190.00 and gave the company a &#34;buy&#34; rating in a research note on Thursday, July 17th. Piper Sandler reiterated an &#34;overweight&#34; rating on shares of Johnson &amp; Johnson in a research report on Thursday, July 17th. Bank of America lifted their price objective on Johnson &amp; Johnson from $161.00 to $175.00 and gave the stock a &#34;neutral&#34; rating in a research report on Thursday, July 17th. Finally, Benchmark upgraded Johnson &amp; Johnson to a &#34;strong-buy&#34; rating in a report on Thursday, April 24th. Nine equities research analysts have rated the stock with a hold rating, ten have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $174.50.</p>
<div class="lb-trans"><p>几家券商最近对 JNJ 进行了评论。Wall Street Zen 在 7 月 18 日的研究报告中将强生的评级从 “强力买入” 下调至 “买入”。瑞银集团在 7 月 17 日的研究报告中将强生的目标价从 180.00 美元上调至 190.00 美元，并给予该公司 “买入” 评级。Piper Sandler 在 7 月 17 日的研究报告中重申了对强生股票的 “增持” 评级。美国银行在 7 月 17 日的研究报告中将强生的目标价从 161.00 美元上调至 175.00 美元，并给予该股票 “中性” 评级。最后，Benchmark 在 4 月 24 日的报告中将强生升级为 “强力买入” 评级。九位股票研究分析师对该股票给予了持有评级，十位给予了买入评级，两位给予了强力买入评级。根据 MarketBeat 的数据，该公司目前的共识评级为 “适度买入”，平均目标价为 174.50 美元。</p>
</div><ul>
<li>3 Big Dividend Plays With Strong Earnings to Back Them</li>
</ul>
<div class="lb-trans"><ul>
<li>三只强劲盈利的高分红股票</li>
</ul>
</div><p><strong>Get Our Latest Stock Report on Johnson &amp; Johnson</strong></p>
<div class="lb-trans"><p><strong>获取我们关于强生的最新股票报告</strong></p>
</div><h2>Johnson &amp; Johnson Stock Performance</h2>
<div class="lb-trans"><h2>强生股票表现</h2>
</div><p>Shares of JNJ opened at $171.41 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.01 and a quick ratio of 0.76. Johnson &amp; Johnson has a one year low of $140.68 and a one year high of $172.18. The company's fifty day moving average price is $158.89 and its 200 day moving average price is $157.27. The company has a market capitalization of $412.81 billion, a PE ratio of 18.33, a price-to-earnings-growth ratio of 2.17 and a beta of 0.41.</p>
<div class="lb-trans"><p>强生的股票在周五开盘价为 171.41 美元。该公司的债务与股本比率为 0.50，流动比率为 1.01，速动比率为 0.76。强生的年内最低价为 140.68 美元，年内最高价为 172.18 美元。该公司的 50 日移动平均价格为 158.89 美元，200 日移动平均价格为 157.27 美元。该公司的市值为 4,128.1 亿美元，市盈率为 18.33，市盈增长比率为 2.17，贝塔值为 0.41。</p>
</div><ul>
<li>4 Major Stocks Raise 2025 Guidance, Analyst Targets Rise</li>
</ul>
<div class="lb-trans"><ul>
<li>四只主要股票上调 2025 年指引，分析师目标上升</li>
</ul>
</div><p>Johnson &amp; Johnson (NYSE:JNJ - Get Free Report) last released its quarterly earnings results on Wednesday, July 16th. The company reported $2.77 EPS for the quarter, topping analysts' consensus estimates of $2.68 by $0.09. The company had revenue of $23.74 billion for the quarter, compared to analyst estimates of $22.85 billion. Johnson &amp; Johnson had a return on equity of 32.49% and a net margin of 25.00%. Johnson &amp; Johnson's revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the firm posted $2.82 earnings per share. As a group, analysts expect that Johnson &amp; Johnson will post 10.58 earnings per share for the current year.</p>
<div class="lb-trans"><p>强生（NYSE:JNJ - 获取免费报告）最近于 7 月 16 日发布了季度财报。该公司报告季度每股收益为 2.77 美元，超出分析师一致预期的 2.68 美元，超出 0.09 美元。该公司季度收入为 237.4 亿美元，而分析师预期为 228.5 亿美元。强生的股本回报率为 32.49%，净利润率为 25.00%。强生的收入较去年同期增长了 5.8%。去年同期，该公司每股收益为 2.82 美元。整体而言，分析师预计强生在当前年度的每股收益将达到 10.58 美元。</p>
</div><h2>Johnson &amp; Johnson Dividend Announcement</h2>
<div class="lb-trans"><h2>强生分红公告</h2>
</div><p>The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 9th. Shareholders of record on Tuesday, August 26th will be given a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 3.0%. The ex-dividend date of this dividend is Tuesday, August 26th. Johnson &amp; Johnson's dividend payout ratio (DPR) is currently 55.61%.</p>
<div class="lb-trans"><p>该公司最近还宣布了一项季度分红，将于 9 月 9 日（星期二）支付。8 月 26 日（星期二）的股东将获得 1.30 美元的分红。这相当于每年 5.20 美元的分红，收益率为 3.0%。该分红的除息日为 8 月 26 日（星期二）。强生的分红支付比率（DPR）目前为 55.61%。</p>
</div><h2>Johnson &amp; Johnson Profile</h2>
<div class="lb-trans"><h2>强生简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Johnson &amp; Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.</p>
<div class="lb-trans"><p>强生是一家控股公司，专注于医疗保健领域的产品研究、开发、制造和销售。它通过创新药物和医疗技术两个部门运营。创新药物部门专注于免疫学、传染病、神经科学、肿瘤学、心血管和代谢以及肺动脉高压。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Johnson &amp; Johnson</li>
<li>How to Calculate Stock Profit</li>
<li>3 AI Infrastructure Stocks Powering the Next Tech Revolution</li>
<li>How to Use the MarketBeat Stock Screener</li>
<li>Why Monolithic Power's Earnings and Guidance Ignited a Rally</li>
<li>What is the Dogs of the Dow Strategy? Overview and Examples</li>
<li>AppLovin’s Q2 Miss Spooks Market, But Wall Street Doubles Down</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过强生</li>
<li>如何计算股票利润</li>
<li>三只推动下一次科技革命的人工智能基础设施股票</li>
<li>如何使用 MarketBeat 股票筛选器</li>
<li>为什么单片电源的收益和指引引发了反弹</li>
<li>什么是道琼斯狗策略？概述和示例</li>
<li>AppLovin 的第二季度业绩不佳让市场感到恐慌，但华尔街却加倍下注</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUpOSg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=JNJ"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，旨在为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Johnson &amp; Johnson Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在强生吗？</h2>
</div><p>Before you consider Johnson &amp; Johnson, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑强生之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson &amp; Johnson wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而强生并不在名单上。</p>
</div><p>While Johnson &amp; Johnson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然强生目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

LaSalle St. Investment Advisors LLC 收购了强生公司（纽约证券交易所代码：JNJ）的 1,776 股股票